Author

Kate Li

Observed names: K. Li, Kate L. Li, Li, K.

Institutions: Actinium Pharmaceuticals (United States), Karyopharm Therapeutics (United States)

Observed institutions: Chinese University of Hong Kong, Ningbo No. 2 Hospital, Actinium Pharmaceuticals (United States), Karyopharm Therapeutics (United States), Weill Cornell Medicine

ORCID: 0009-0002-8643-3343

Observed ORCID: 0009-0002-8643-3343

OpenAlex ID: A5031202942

Lineage-specific intolerance to oncogenic drivers restricts histological transformation

2024 · Eric E. Gardner, Ethan M. Earlie, et al. · Science · 121

Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia

2025 · Sameem M. Abedin, Guru Subramanian Guru Murthy, et al. · Leukemia · 17

Genome-wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase

2024 · John R. Ferrarone, Jerin Thomas, et al. · Proceedings of the National Academy of Sciences · 11

44P Long-term follow-up of selinexor (SEL) maintenance treatment in patients with TP53 wild type (wt) advanced/recurrent (A/R) endometrial cancer (EC): Intermediate endpoints by mismatch repair (MMR) status in the ENGOT-EN5/GOG-3055/SIENDO study

2025 · J.A. Perez Fidalgo, I.B. Vergote, et al. · ESMO Open

AML-545 Long-Term Follow-up Demonstrates Ongoing Efficacy Benefit of 131I-Apamistamab-led Allogeneic Hematopoietic Cell Transplantation in Older Patients With Active, R/R AML in the Phase 3 SIERRA Trial

2024 · Stuart Seropian, Boglarka Gyurkocza, et al. · Clinical Lymphoma Myeloma & Leukemia

Long-Term Follow-Up Demonstrates Ongoing Efficacy Benefit of 131I-Apamistamab-led Allogeneic Hematopoietic Cell Transplantation in Older Patients With Active, R/R AML in the Phase 3 SIERRA Trial

2024 · Stuart Seropian, Boglarka Gyurkocza, et al. · Clinical Lymphoma Myeloma & Leukemia

90P Predictive and prognostic factors in metastatic colorectal cancer patients treated with fruquintinib: A multicenter real-world analysis

2024 · C. Zhang, Y. Wang, et al. · Annals of Oncology

Supplementary Material for: A Prospective Cohort Study of Fecal miR-223 and miR-451a as Noninvasive and Specific Biomarkers for Diagnosis of Necrotizing Enterocolitis in Preterm Infants

2020 · Ng, P.C., K.Y.Y., Chan, et al. · Figshare

Pf222 Epigenetic Silencing of Cd9 Confers Poor Survival in Pediatric Acute Myeloid Leukemia and Aggravates Disease Progression

2019 · H. Wang, T.K. F. Man, et al. · HemaSphere

Works count: 9

Citation count: 149

H-index: 3

I10-index: 3